Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors

Overview

Journal J Nat Prod

Date 2021 May 11

PMID 33974423

Citations 5

Authors

Arun K Ghosh

Jennifer L Mishevich

Melissa S Jurica

Affiliations

Soon will be listed here.

Abstract

Spliceostatins and thailanstatins are intriguing natural products due to their structural features as well as their biological significance. This family of natural products has been the subject of immense synthetic interest because they exhibit very potent cytotoxicity in representative human cancer cell lines. The cytotoxic properties of these natural products are related to their ability to inhibit spliceosomes. FR901564 and spliceostatins have been shown to inhibit spliceosomes by binding to their SF3B component. Structurally, these natural products contain two highly functionalized tetrahydropyran rings with multiple stereogenic centers joined by a diene moiety and an acyclic side chain linked with an amide bond. Total syntheses of this family of natural products led to the development of useful synthetic strategies, which enabled the synthesis of potent derivatives. The spliceosome modulating properties of spliceostatins and synthetic derivatives opened the door for understanding the underlying spliceosome mechanism as well as the development of new therapies based upon small-molecule splicing modulators. This review outlines the total synthesis of spliceostatins, synthetic studies of structural derivatives, and their bioactivity.

Citing Articles

Small molecules modulating RNA splicing: a review of targets and future perspectives.

Bouton L, Ecoutin A, Malard F, Campagne S RSC Med Chem. 2024; 15(4):1109-1126.

PMID: 38665842 PMC: 11042171. DOI: 10.1039/d3md00685a.

Structural insights into branch site proofreading by human spliceosome.

Zhang X, Zhan X, Bian T, Yang F, Li P, Lu Y Nat Struct Mol Biol. 2024; 31(5):835-845.

PMID: 38196034 DOI: 10.1038/s41594-023-01188-0.

The Evolving Landscape of Antibody-Drug Conjugates: In Depth Analysis of Recent Research Progress.

Sasso J, Tenchov R, Bird R, Iyer K, Ralhan K, Rodriguez Y Bioconjug Chem. 2023; 34(11):1951-2000.

PMID: 37821099 PMC: 10655051. DOI: 10.1021/acs.bioconjchem.3c00374.

Recent updates and future perspectives in aziridine synthesis and reactivity.

Dequina H, Jones C, Schomaker J Chem. 2023; 9(7):1658-1701.

PMID: 37681216 PMC: 10482075. DOI: 10.1016/j.chempr.2023.04.010.

Stereochemical Control of Splice Modulation in FD-895 Analogues.

Chan W, Trieger K, La Clair J, Jamieson C, Burkart M J Med Chem. 2023; 66(10):6577-6590.

PMID: 37155693 PMC: 10586521. DOI: 10.1021/acs.jmedchem.2c01893.

References

Cretu C, Agrawal A, Cook A, Will C, Fekkes P, Smith P . Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds. Mol Cell. 2018; 70(2):265-273.e8. DOI: 10.1016/j.molcel.2018.03.011. View

Nakajima H, Hori Y, Terano H, OKUHARA M, Manda T, Matsumoto S . New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J Antibiot (Tokyo). 1996; 49(12):1204-11. DOI: 10.7164/antibiotics.49.1204. View

Effenberger K, Urabe V, Prichard B, Ghosh A, Jurica M . Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages. RNA. 2016; 22(3):350-9. PMC: 4748813. DOI: 10.1261/rna.053108.115. View

Hayashi Y, Gotoh H, Hayashi T, Shoji M . Diphenylprolinol silyl ethers as efficient organocatalysts for the asymmetric Michael reaction of aldehydes and nitroalkenes. Angew Chem Int Ed Engl. 2005; 44(27):4212-5. DOI: 10.1002/anie.200500599. View

Trost B, Quintard A . Asymmetric catalytic alkynylation of acetaldehyde: application to the synthesis of (+)-tetrahydropyrenophorol. Angew Chem Int Ed Engl. 2012; 51(27):6704-8. PMC: 3428070. DOI: 10.1002/anie.201203035. View

Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K . Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol. 2007; 3(9):576-83. DOI: 10.1038/nchembio.2007.18. View

Ghosh A, Wang Y, Kim J . Total synthesis of microtubule-stabilizing agent (-)-laulimalide. J Org Chem. 2001; 66(26):8973-82. DOI: 10.1021/jo010854h. View

Takai K, Tagashira M, Kuroda T, Oshima K, Utimoto K, Nozaki H . Reactions of alkenylchromium reagents prepared from alkenyl trifluoromethanesulfonates (triflates) with chromium(II) chloride under nickel catalysis. J Am Chem Soc. 2011; 108(19):6048-50. DOI: 10.1021/ja00279a068. View

Michrowska A, Bujok R, Harutyunyan S, Sashuk V, Dolgonos G, Grela K . Nitro-substituted Hoveyda-Grubbs ruthenium carbenes: enhancement of catalyst activity through electronic activation. J Am Chem Soc. 2004; 126(30):9318-25. DOI: 10.1021/ja048794v. View

10.

Scotti M, Swanson M . RNA mis-splicing in disease. Nat Rev Genet. 2015; 17(1):19-32. PMC: 5993438. DOI: 10.1038/nrg.2015.3. View

11.

Lennox A, Lloyd-Jones G . Selection of boron reagents for Suzuki-Miyaura coupling. Chem Soc Rev. 2013; 43(1):412-43. DOI: 10.1039/c3cs60197h. View

12.

Franzen J, Marigo M, Fielenbach D, Wabnitz T, Kjaersgaard A, Anker Jorgensen K . A general organocatalyst for direct alpha-functionalization of aldehydes: stereoselective C-C, C-N, C-F, C-Br, and C-S bond-forming reactions. Scope and mechanistic insights. J Am Chem Soc. 2005; 127(51):18296-304. DOI: 10.1021/ja056120u. View

13.

Gazaille J, Abramite J, Sammakia T . Toward the synthesis of (+)-peloruside A via an intramolecular vinylogous aldol reaction. Org Lett. 2011; 14(1):178-81. PMC: 3272878. DOI: 10.1021/ol202966m. View

14.

Daguenet E, Dujardin G, Valcarcel J . The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep. 2015; 16(12):1640-55. PMC: 4693517. DOI: 10.15252/embr.201541116. View

15.

Smith Iii A, Lin Q, Doughty V, Zhuang L, McBriar M, Kerns J . The Spongistatins: Architecturally Complex Natural Products-Part Two: Synthesis of the C(29-51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2 Financial support was provided by the National Institutes of Health (National.... Angew Chem Int Ed Engl. 2001; 40(1):196-199. View

16.

Albert B, Sivaramakrishnan A, Naka T, Koide K . Total synthesis of FR901464, an antitumor agent that regulates the transcription of oncogenes and tumor suppressor genes. J Am Chem Soc. 2006; 128(9):2792-3. DOI: 10.1021/ja058216u. View

17.

Wilkinson M, Charenton C, Nagai K . RNA Splicing by the Spliceosome. Annu Rev Biochem. 2019; 89:359-388. DOI: 10.1146/annurev-biochem-091719-064225. View

18.

Nakajima H, Sato B, Fujita T, Takase S, Terano H, OKUHARA M . New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo). 1996; 49(12):1196-203. DOI: 10.7164/antibiotics.49.1196. View

19.

Liu X, Biswas S, Berg M, Antapli C, Xie F, Wang Q . Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod. 2013; 76(4):685-93. PMC: 3696399. DOI: 10.1021/np300913h. View

20.

Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View